Alexandria Venture Investments
Venture Capital
Active
Pasadena, United States
220
53M
175
7.86
9
0.19
23
- Areas of investment
Summary
We also calculated 3 valuable employees in our database.
The higher amount of exits for fund were in 2019. The real fund results show that this VC is 13 percentage points less often commits exit comparing to other companies. The fund is constantly included in 25-48 investment rounds annually. Opposing the other organizations, this Alexandria Venture Investments works on 17 percentage points less the average amount of lead investments. The typical startup value when the investment from Alexandria Venture Investments is more than 1 billion dollars. Deals in the range of 50 - 100 millions dollars are the general things for fund. The top activity for fund was in 2018.
The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Alexandria Venture Investments, startups are often financed by ARCH Venture Partners, 5AM Ventures, Alexandria Real Estate Equities. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, OrbiMed, 5AM Ventures. In the next rounds fund is usually obtained by Tim Disney, The Duke of Bedford, Illumina Ventures.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Biotechnology, Biopharma. Among the most popular portfolio startups of the fund, we may highlight Moderna Therapeutics, Epic Sciences, Codiak Biosciences.
Investor highlights
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 220
- Lead investments
- 9
- Exits
- 23
- Rounds per year
- 7.86
- Follow on index
- 0.19
- Investments by industry
- Biotechnology (196)
- Health Care (97)
- Therapeutics (79)
- Medical (46)
- Life Science (41) Show 57 more
- Investments by region
-
- United States (201)
- Canada (4)
- Switzerland (2)
- France (3)
- China (1) Show 2 more
- Peak activity year
- 2021
- Number of Unicorns
- 4
- Number of Decacorns
- 4
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 79M
- Group Appearance index
- 0.99
- Avg. company exit year
- 9
- Avg. multiplicator
- 3.12
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Bright Peak Therapeutics | 11 Jun 2024 | Biotechnology, Therapeutics | Late Stage Venture | 90M | Switzerland, Basel-City, Basel |
Tr1x | 17 Jan 2024 | Biotechnology, Health Care, Medical, Life Science | Early Stage Venture | 75M | United States, California, La Jolla |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.